Xiaofen Pan
Impact in
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
-
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 4
- Protein Tyrosine Phosphatases 3
-
- Gastric Cancer Management and Outcomes 4
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Zhang Zhang (3 shared papers)Gang Peng (5 shared papers)Xiaomei Ren (3 shared papers)Ke Ding (3 shared papers)Xiaoxi Zhuang (2 shared papers)Fengxiang Zhang (4 shared papers)Zhonghua Yu (2 shared papers)Yupeng Li (2 shared papers)
- Journals
- Clinical Radiology (3 papers)Journal of Medicinal Chemistry (3 papers)Frontiers in Oncology (2 papers)Recent Patents on Anti-Cancer Drug Discovery (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Xiaofen Pan
31 papers receiving 700 citations
Peers
Comparison fields: 5 of 89
- Hematology 141
- Cancer Research 131
- Gastroenterology 38
- Genetics 67
- Pulmonary and Respiratory Medicine 170
Countries citing papers authored by Xiaofen Pan
This map shows the geographic impact of Xiaofen Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofen Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofen Pan more than expected).
Fields of papers citing papers by Xiaofen Pan
This network shows the impact of papers produced by Xiaofen Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofen Pan. The network helps show where Xiaofen Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofen Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 131 | |
| 2 | 2019 | 101 | |
| 3 | 2013 | 64 | |
| 4 | 2021 | 45 | |
| 5 | 2009 | 40 | |
| 6 | 2018 | 39 | |
| 7 | 2012 | 35 | |
| 8 | 2012 | 33 | |
| 9 | 2010 | 30 | |
| 10 | 2012 | 28 | |
| 11 | 2017 | 27 | |
| 12 | 2015 | 20 | |
| 13 | 2009 | 18 | |
| 14 | 2013 | 17 | |
| 15 | 2015 | 15 | |
| 16 | 2015 | 12 | |
| 17 | 2015 | 8 | |
| 18 | 2016 | 7 | |
| 19 | 2022 | 7 | |
| 20 | 2021 | 6 |
About Xiaofen Pan
Xiaofen Pan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Surgery, having authored 35 papers that have together received 706 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Gastric Cancer Management and Outcomes (4 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Viral Infections and Immunology Research (3 papers), Protein Tyrosine Phosphatases (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Hematology (141 citations), Cancer Research (131 citations), Gastroenterology (38 citations), Genetics (67 citations) and Pulmonary and Respiratory Medicine (170 citations). Xiaofen Pan has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Zhang Zhang, Gang Peng, Xiaomei Ren, Ke Ding, Xiaoxi Zhuang, Fengxiang Zhang, Zhonghua Yu, Yupeng Li, Sha Liu and Xiaoyun Lu. Their work appears in journals such as Clinical Radiology, Journal of Medicinal Chemistry, Frontiers in Oncology, Recent Patents on Anti-Cancer Drug Discovery and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.